在儿童肝细胞母细胞瘤的个性化化疗和疗效分析
Huimin Hu1, Weiling Zhang1, Yi Zhang1
1Department of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Pediatric blood & cancer
|November 8, 2023
概括
迷你患者衍生异种移植 (MiniPDX) 模型有效选儿科肝母细胞瘤的个性化化疗,显著提高了患有这种罕见癌症的儿童的完全缓解率和生存结果.
科学领域:
- 在瘤学瘤学.
- 儿科瘤学 儿科瘤学
- 翻译研究是翻译研究.
背景情况:
- 儿科肝母细胞瘤治疗经常面临化学疗法耐药性和复发的挑战.
- 个性化治疗策略对于改善儿科肝癌的治疗结果至关重要.
研究的目的:
- 评估微型患者衍生异种移植 (MiniPDX) 模型的临床实用性.
- 选针对儿科肝母细胞瘤的个性化化疗方案.
主要方法:
- 从31名患有肝母细胞瘤的儿童的瘤组织中建立了 MiniPDX 模型.
- 测试了五种化疗方案的敏感性,以确定最有效的疗法.
- 将MiniPDX引导治疗与常规化疗进行比较.
主要成果:
- 以MiniPDX为指导的实验组实现了80.64%的完全缓解率 (CR).
- 与对照组相比,IV期病例的CR率 (73.68%对37.5%) 和3年无事件生存率 (79.3%对26.7%) 显著提高.
- 确定了针对个性化治疗的特定有效的多药化疗组合.
结论:
- 迷你PDX模型是选个性化化疗方案的宝贵工具.
- 这种方法显著提高了儿科肝母细胞瘤的完全缓解率.
更多相关视频
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.4K
11:09Establishing Intracranial Brain Tumor Xenografts With Subsequent Analysis of Tumor Growth and Response to Therapy using Bioluminescence Imaging
Published on: July 13, 2010
39.4K
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
